The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bel'tsevich D.G.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Troshina E.A.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Iukina M.Iu.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Pheochromocytoma

Authors:

Bel'tsevich D.G., Troshina E.A., Iukina M.Iu.

More about the authors

Journal: Problems of Endocrinology. 2010;56(1): 63‑71

Read: 12804 times


To cite this article:

Bel'tsevich DG, Troshina EA, Iukina MIu. Pheochromocytoma. Problems of Endocrinology. 2010;56(1):63‑71. (In Russ.)

Recommended articles:
Unre­solved problem: Chemotherapy-Induced Peri­pheral Neuropathy. P.A. Herzen Journal of Onco­logy. 2024;(5):76-81
Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):517-524
Tube­rculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66
Epidemiology of suicidal beha­vior in children and adolescents worldwide. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):16-26
Modern view on the etiology of gallstone disease in children. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):59-68
Difficulties in life­time diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Clinical and epidemiological characteristics of myasthenia in the Altai region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):198-202

References:

  1. Platts J.K., Drew P.J., Harvey J.N. Death from phaeochromocytoma: lessons from a post-mortem survey. J R Coll Physicians London 1995; 29:299–306.
  2. McNeil A.R., Blok B.H., Koelmeyer T.D. et al. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust N J Med 2000; 30: 6: 648-652.
  3. Sutton M.G., Sheps S.G., Lie J.T. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 1981;56:354–360.
  4. Kushakovskii M.S. Feokhromotsitomy. Gipertonicheskaya bolezn' i vtorichnye arterial'nye gipertenzii. L: Meditsina 1983; 239-250.
  5. Kalinin A.P., Kazantseva I.A., Polyakova G.A. Nadpochechnikovye i vnenadpochechnikovye feokhromotsitomy. Uchebnoe posobie. M 1998; 36.
  6. Dedov I.I., Bel'tsevich D.G., Kuznetsov N.S., Mel'nichenko G.A. Feokhromotsitoma. M: Prakticheskaya meditsina 2005; 216.
  7. Kuznetsov N.S., Bel'tsevich D.G., Lysenko M.A. Feokhromotsitoma. Rus vrach 2002; 7.
  8. Bravo E.L., Tagle R. Pheochromocytoma: state of-the-art and future prospects. Endocr Rev 2003;24: 539-553.
  9. Neumann H.P.H. et al. Germ-line mutations in nonsyndromic pheochromocytoma. New Engl J Med 2002; 346: 1459-1466.
  10. Gimenez-Roqueplo A.P. et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 2003; 63: 5615-5621.
  11. Eisenhofer G. et al. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 1999; 340: 1872-1879.
  12. Lack E.E. et al. Recommendations for the reporting of extra-adrenal paragangliomas. The Association of Directors of Anatomic and Surgical Pathology. Hum Pathol 2003; 34: 112-113.
  13. Maher E.R. et al. Von Hippel-Lindau disease: a genetic study. J Med Genet 1991; 443-447.
  14. Eisenhofer G. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab 1998; 83: 2175-2185.
  15. Goldstein R.E., O'Neill J.A., George W. et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg 1999; 229: 6: 755-759.
  16. Eisenhofer G. et al. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor. Endocr Pathol 2003; 14: 193-212.
  17. Lenders J.W. et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002; 287: 1427-1434.
  18. Guller U. et al. Detecting pheochromocytoma: defining the most sensitive test. Ann Surg 2006; 243: 102-107.
  19. Furuta N. et al. Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy. Int J Urol 1999; 6: 119-124.
  20. Ilias I. et al. 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the evaluation of patients with pheochromocytoma. Abstract P3-511. Presented at the 84th Annual Meeting of the Endocrine Society, 19-22.06.02, San Fransisco, CA 2002.
  21. Orlo H., Clark et al. Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network. 2008; 1. www.nccn.org
  22. Linnoila R.I. et al. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 1990; 21: 1168-1180.
  23. Loh K.C. et al. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 1997; 20: 648-658.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.